Laurent Pharmaceuticals Inc.
Clinical stage biopharmaceutical company developing a first-in-class pro-resolving drug, a new treatment paradigm for chronic inflammatory diseases.
Laurent Pharma is a private biotech focusing on severe inflammatory diseases. Laurent is currently conducting a Phase 2 trial in Cystic Fibrosis (CF), expected to create a major inflection point and a first exit opportunity 2020. It has a strategic partnership with CF Foundation ($5M Award) and is supported by a strong syndicate of seed and angel groups ( RSJ Capital, Aligo Innovation, Keiretsu, Anges Quebec, TechCoast, CTAN, SCAN, Cowtown).